Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 1Available 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 1Expanded_access 1

Sponsor

Cancer Type

Head & Neck 2Endocrine 1

Conditions

Parathyroid Neoplasms 2Multiple Endocrine Neoplasia Type 1 1Hyperparathyroidism, Primary 1

Interventions

pembrolizumab 1265Specimen Handling 926Magnetic Resonance Spectroscopy 830Carboplatin 823Cyclophosphamide 800Cisplatin 723Nivolumab 669Paclitaxel 627Radiotherapy 611Gemcitabine 573Biopsy 557Bevacizumab 478Dexamethasone 438fludarabine 407Docetaxel 380venetoclax 368Oxaliplatin 364Capecitabine 358Fluorouracil 355atezolizumab 350durvalumab 332Rituximab 330Drug Therapy 326Doxorubicin 316Radiosurgery 315Standard of Care 309Blood Specimen Collection 308Pemetrexed 305Ipilimumab 299Radiation 286

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
fluorocholine × 1 year × Clear all
NCT07444723 2026-06-02

Accuracy of 18F-Fluorocholine PET/MR and NeuroEXPLORER PET/CT Imaging for Localization of Parathyroid Tumors

National Institutes of Health Clinical Center (CC)

Phase 2/3 Recruiting
193 enrolled
EndocrineHead & Neck

Parathyroid Neoplasms, Multiple Endocrine Neoplasia Type 1, Hyperparathyroidism, Primary

NCT07218224 2025-10-20

Expanded Access:18F-Fluorocholine for the Detection of Parathyroid Adenomas

University of California, San Francisco

Available
Head & Neck

Parathyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡